SG/PUT/AMGEN/250/0.1/17.01.25 | Market Closed - Börse Stuttgart 12:02:45 28/06/2024 pm IST | ||
| 0.47 EUR | -4.08% |
|
| Current month | -42.68% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
| Date | Price | Change |
|---|---|---|
| 28/24/28 | 0.47 | -4.08% |
| 27/24/27 | 0.49 | +8.89% |
| 26/24/26 | 0.45 | -6.25% |
| 25/24/25 | 0.48 | -20.00% |
| 24/24/24 | 0.6 | 0.00% |
Delayed Quote Börse Stuttgart
Last update June 28, 2024 at 12:02 pm IST
More quotesStatic data
| Product type | Plain-Vanilla-Warrants |
|---|---|
| Buy / Sell | PUT |
| Underlying | AMGEN INC. |
| Issuer | 
Société Générale
|
| WKN | SY005U |
| ISIN | DE000SY005U8 |
| Date issued | 29/05/2024 |
| Strike | 250 $ |
| Maturity | 17/01/2025 (203 Days) |
| Parity | 10 : 1 |
| Emission price | 0.8 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 0.96 € |
|---|---|
| Lowest since issue | 0.45 € |
| Spread | 0.01 € |
| Spread % | 1.96% |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
312.4
USD
Average target price
316.4
USD
Spread / Average Target
+1.28%
- Stock Market
- Warrants
- Warrant
